HF1271
IntroducedMNProvisions regarding the sale of cannabinoids derived from hemp modified, person selling edible cannabinoids permitted to convert the person's registration to a comparable hemp license, and hemp-derived topical product provisions modified.
Minnesota · Session 2025
Status
Introduced
As of Feb 20, 2025
Last Action
Author added Gottfried
Official Source
Official Full Bill TextSummary
A Minnesota bill modifies provisions governing the sale of hemp-derived cannabinoids, allows eligible registrants to convert to a comparable hemp license, and updates rules for hemp-derived topical products; a new author has been added. License conversion pathways and modified sale provisions could affect the operational status and compliance requirements of businesses currently registered to sell edible or topical hemp cannabinoid products.
What
A Minnesota bill modifies provisions governing the sale of hemp-derived cannabinoids, allows eligible registrants to convert to a comparable hemp license, and updates rules for hemp-derived topical products; a new author has been added.
Who
retailers and manufacturers
Why
License conversion pathways and modified sale provisions could affect the operational status and compliance requirements of businesses currently registered to sell edible or topical hemp cannabinoid products.
Want to advertise here?
Get your business listed on buyweed.us
Want to advertise here?
Get your business listed on buyweed.us
More Minnesota Cannabis Bills
- SF4401Omnibus Cannabis billPassed
- SF4957Registered designated caregivers provisions modifications and increasing patient and cannabis plant limits expansion provisionIntroduced
- HF3615Cannabis laboratory testing requirements extended.Passed
- SF4877Cannabis license application periods and issuance modificationIntroduced
- SF4871Remediated cannabis product definitionIntroduced
- SF4876Cannabis microbusiness outdoor cultivation limit increaseIntroduced
- HF4733Remediated cannabis product defined, and cannabis business required to disclose information related to remediated cannabis products.Introduced
- SF4875Medical cannabis endorsement requirements modificationIntroduced
- HF4688Cannabis license holders allowed to transport products to testing facilities.Introduced
- HF4577Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated.Introduced
- HF4570Cannabis microbusiness outdoor cultivation limit increased.Introduced
- SF4542Cannabis event provisions modificationIntroduced
LEGISLATIVE DATA PROVIDED BY LEGISCAN · LICENSED UNDER CC BY 4.0 · UPDATED Aug 17, 2026